Commerzbank Aktiengesellschaft Astrazeneca PLC Transaction History

Commerzbank Aktiengesellschaft

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 13, 2019	SELL	$35.49 - $43.02 $1.55 Million - $1.88 Million	-43,656 Closed	0 $0
Q4 2018 Oct 03, 2024	BUY	$36.86 - $41.49 $1.61 Million - $1.81 Million	43,656 New	43,656 $1.66 Million
Q3 2018 Oct 04, 2024	BUY	$34.76 - $39.72 $1.52 Million - $1.73 Million	43,656 New	43,656 $1.73 Million
Q2 2018 Oct 04, 2024	BUY	$34.55 - $37.05 $1.51 Million - $1.62 Million	43,656 New	43,656 $1.53 Million
Q4 2017 Oct 04, 2024	BUY	$32.09 - $34.78 $1.4 Million - $1.52 Million	43,656 New	43,656 $1.52 Million
Q2 2017 Aug 09, 2017	BUY	N/A	43,656	43,656 $1.49 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Commerzbank Aktiengesellschaft , based on Form 13F filings with the SEC.

Stay updated on Commerzbank Aktiengesellschaft with notifications on news.